MRC Translational Immune Discovery Unit
At the MRC Translational Immune Discovery Unit we pioneer the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases. We innovate some of our leading discoveries to create new medicines.
The MRC TIDU consists of 13 research teams with over 130 scientists. We define the unknown in human immune pathogenesis for the benefit of patients.
Collaboration and innovation lie at the heart of the MRC TIDU. Our research groups work together to understand how the human immune system functions, what happens when it fails, and how we can use our knowledge of these systems to improve patient outcomes. By working together with clinicians, industry and charities, we aim to translate our scientific findings at the TIDU so that they can have a positive impact on global health.
- Professor Alison Simmons